MediWound Ltd.

NASDAQ: MDWD · Real-Time Price · USD
18.11
-0.46 (-2.48%)
At close: Aug 15, 2025, 3:59 PM
18.10
-0.06%
After-hours: Aug 15, 2025, 04:10 PM EDT

MediWound Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
19.21M 20.22M 19.72M 20.14M 19.85M 18.69M 24.97M 25.99M 25.89M 26.5M 20.36M 20.93M 22.32M 23.76M 24.95M 25.2M 23.17M
Cost of Revenue
16.45M 17.59M 17.27M 17.47M 16.49M 15.11M 13.95M 13.44M 13.36M 13.33M 13.82M 14.37M 14.51M 14.99M 15.39M 15.33M 14.44M
Gross Profit
2.77M 2.63M 2.45M 2.67M 3.36M 3.58M 11.02M 12.55M 12.53M 13.16M 6.55M 6.57M 7.82M 8.77M 9.56M 9.88M 8.73M
Operating Income
-20.89M -19.4M -17.19M -15.14M -14.66M -15.29M -20.84M -21.32M -20.68M -19.6M -13.68M -13.05M -12.58M -11.22M -10.09M -8.74M -8.55M
Interest Income
7.3M 2.79M 2.85M 3.73M 8.98M 9.65M 7.82M 7.04M 1.22M 685K 247K 150K 257K 129K 556K 649K 632K
Pretax Income
-21.18M -30.16M -27.9M -19.78M -12.55M -6.53M -12.3M -14.35M -19.62M -19.52M -16.29M -15.43M -14.26M -13.52M -11.1M -9.75M -9.67M
Net Income
-21.22M -30.22M -28.06M -19.97M -12.75M -6.72M -12.43M -14.43M -19.7M -19.6M -16.3M -15.45M -14.29M -13.55M -11.12M -9.69M -9.59M
Selling & General & Admin
13.11M 12.91M 11.7M 11.07M 11.16M 11.38M 11.78M 12.23M 11.4M 10.64M 10.28M 9.66M 9.98M 9.74M 9.52M 9.25M 8.96M
Research & Development
10.29M 8.88M 7.7M 6.71M 6.83M 7.47M 8.36M 9.71M 9.88M 10.18M 9.94M 9.96M 10.42M 10.26M 10.02M 9.27M 8.22M
Other Expenses
250K 246K n/a n/a n/a n/a 958K 958K 958K 958K n/a n/a n/a n/a 108K 108K 108K
Operating Expenses
23.66M 22.03M 19.63M 17.79M 18.01M 18.86M 20.6M 22.62M 21.96M 21.51M 20.23M 19.62M 20.4M 19.99M 19.65M 18.62M 17.29M
Interest Expense
7.58M 13.56M 13.56M 8.38M 6.86M 893K 1.93M 2.71M 2.5M 2.94M 2.54M 2.22M 1.93M 2.43M 1.8M 1.88M 1.97M
Selling & Marketing Expenses
3.3M 3.2M 8.31M 7.25M 7.36M 7.28M 3.13M 3.13M 2.73M 2.55M 2.69M 3.57M 3.48M 3.39M 2.44M 2.28M 2.28M
Cost & Expenses
40.1M 39.62M 36.9M 35.27M 34.5M 33.96M 34.55M 36.06M 35.31M 34.84M 34.05M 33.99M 34.91M 34.98M 35.03M 33.95M 31.73M
Income Tax Expense
42K 61K 163K 190K 204K 185K 130K 87K 79K 78K 17K 16K 31K 27K 23K 19K n/a
Shares Outstanding (Basic)
10.37M 10.79M 10.51M 9.28M 9.23M 9.22M 9.22M 9.21M 8.39M 6.33M 4.78M 4.73M 4.11M 3.89M 3.89M 3.89M 3.89M
Shares Outstanding (Diluted)
10.8M 10.79M 10.51M 9.28M 9.23M 9.22M 9.22M 9.21M 8.39M 6.33M 4.78M 4.73M 4.11M 3.89M 3.89M 3.89M 3.89M
EPS (Basic)
-2.09 -3.07 -2.9 -2.16 -1.38 -0.77 -1.76 -2.4 -3.42 -3.85 -3.72 -3.68 -3.6 -3.43 -2.83 -2.48 -2.44
EPS (Diluted)
-2.09 -3.07 -2.9 -2.16 -1.38 -0.77 -1.76 -2.4 -3.42 -3.85 -3.74 -3.7 -3.62 -3.45 -2.83 -2.48 -2.41
EBITDA
-29.43M -27.93M -13.49M -11.46M -11.02M -11.72M -19.21M -19.69M -19.35M -18.25M -12.72M -12.1M -11.21M -9.9M -8.42M -7.09M -6.96M
EBIT
-30.9M -29.41M -14.92M -12.87M -12.39M -13.02M -20.45M -20.84M -20.5M -19.42M -13.89M -13.36M -12.47M -11.1M -9.57M -8.23M -8.06M
Depreciation & Amortization
1.47M 1.48M 1.43M 1.41M 1.37M 1.3M 1.24M 1.24M 1.25M 1.27M 1.26M 1.26M 1.25M 1.2M 1.15M 1.14M 1.09M